The use of mesenchymal stromal cells (MSCs) differentiated toward a smooth muscle cell (SMC) phenotype may provide an alternative for investigators interested in regenerating urinary tract organs such as the bladder where autologous smooth muscle cells cannot be used or are unavailable. In this study we measured the effects of good manufacturing practice (GMP)-compliant expansion followed by myogenic differentiation of human MSCs on the expression of a range of contractile (from early to late) myogenic markers in relation to the electrophysiological parameters to assess the functional role of the differentiated MSCs and found that differentiation of MSCs associated with electrophysiological competence comparable to bladder SMCs. Within 1-2 weeks of myogenic differentiation, differentiating MSCs significantly expressed alpha smooth muscle actin (αSMA; ACTA2), transgelin (TAGLN), calponin (CNN1), and smooth muscle myosin heavy chain (SM-MHC; MYH11) according to qRT-PCR and/or immunofluorescence and Western blot. Voltage-gated Na + current levels also increased within the same time period following myogenic differentiation. 
Introduction
The smooth muscle of the urinary tract is subjected to a variety of diseases and pathologies. Injury, loss or degeneration of urinary tract smooth muscle can severely alter micturition patterns and hence the quality of life. Although a number of treatments are available, limitations such as complications or recurrence have motivated investigators to seek out therapies that may provide safer and longer-lasting outcomes by repairing the damaged tissue itself.
In cell-based tissue engineering of the human bladder autologous bladder cells are sometimes used as a cell source. While clinical trials using autologous bladder smooth muscle cells (SMCs) show that such cell-based approaches seem promising for bladder tissue regeneration [1] [2] [3] , one problem with this approach is that bladder cells are unavailable in some patients (e.g. diseased or malignant bladders). In such cases bladder cells cannot be used for regenerative therapies. Human mesenchymal stromal cells (MSCs) are multipotent adult progenitor cells capable of differentiating into a variety of cell types and have regenerative potential [4, 5] . Over the past decade injection of MSCs has been assessed in humans for the treatment of urinary incontinence [6] [7] [8] [9] . Although these highly valuable studies have shown an improvement in urethral closure pressure of the urethral sphincter, there is no clear evidence that these cells reconstruct the muscle. Moreover, some studies investigating stem cell therapy for urinary incontinence or bladder dysfunction have shown that only a small fraction of the undifferentiated MSCs have differentiated into smooth muscle in situ [10] [11] [12] . The use of MSCs differentiated toward a SMC phenotype may provide an alternative for investigators interested in regenerating urinary tract organs.
The contractile property of smooth muscle plays an important functional role in urinary tract organs by allowing dynamic changes in luminal volume such as in the urinary bladder where smooth muscle in the wall relaxes during filling and contracts forcefully to expel urine during micturition [13] or in supporting urethral storage pressure during bladder filling and storage which is partially aided by the internal urethral sphincter smooth muscle [14] . Ion channels in the smooth muscle membranes are essential in determining these functional properties [13] .
There are a number of methodologies for differentiating MSCs to SMCs in vitro. For example, co-culture of MSCs with bladder SMCs or conditioned medium from those cells have been used to differentiate MSCs into SMCs [15] [16] [17] . The experimental differentiation of MSCs toward the smooth muscle lineage has also been described using various combinations of biochemical factors such as transforming growth factor beta 1 (TGF-β1) [17] [18] [19] [20] [21] [22] [23] [24] [25] , L-ascorbic acid (also known as vitamin C) [21, 22, 25, 26] or platelet derived growth factor (PDGF-BB) [17, 22, 23, 26] . Moreover various human sources including MSCs isolated from bone marrow, adipose tissue and hair follicles were differentiated in vitro to generate smooth muscle-cell like cells. However, the electrophysiological competence of differentiated cells was not investigated in those studies. Therefore the aim of this study was to measure the effects of good manufacturing practice (GMP)-compliant expansion followed by myogenic differentiation of human MSCs using TGF-β1, ascorbic acid and PDGF-AB on the expression of a range of contractile myogenic markers in addition to the electrophysiological properties to assess the functional role of differentiated MSCs in comparison to bladder smooth muscle cells.
Materials and Methods
Human tissue used in this study was obtained according to institutional approval from the University of Tübingen research ethics committee (623/2013BO2) and with written informed donor consent obtained for the use of this sample in research.
Isolation and Expansion of Human MSCs
Bone marrow was obtained from the proximal femur during routine hip replacement by the BG Trauma Clinic (Tübingen, Germany). Bone marrow was washed with PBS, centrifuged at 150 x g (10 min at RT), the supernatant was discarded and cells were resuspended in PBS. MSCs were isolated using a Ficoll 1 density gradient fractionation (density 1.077 g/mL, GE Healthcare Life Sciences, Uppsala, Sweden; 400 x g, 30 min, RT). The mononuclear cell layer was harvested, washed with PBS and seeded in T75 flasks (BD Falcon, Heidelberg) and expanded in GMP-compliant expansion medium: DMEM low glucose (Sigma-Aldrich, Taufkirchen, Germany), 1000 IU heparin (Carl Roth, Karlsruhe, Germany), 25 mM HEPES (Lonza, Basel, Switzerland), 5% human plasma (TCS Biosciences, Buckingham, UK), 5% human pooled platelet lysate (PPL, 10 8 platelets/mL medium; Blood Donation Center Tübingen, Germany), 2mM L-glutamine (Lonza) and 1% penicillin-streptomycin (Life Technologies, Darmstadt, Germany). After 24 hours of incubation the media was discarded and replaced to remove unattached cells and media was changed twice a week. After 5-7 days, cells were removed with Accutase (PAA, Pasching Austria), counted and re-seeded in GMP expansion medium (passage 1, density 1.5x10 5 cells per flask).
Human Bladder Smooth Muscle Cells
Human bladder SMCs (Promocell, Heidelberg, Germany) were cultured in smooth muscle cell growth medium 2 (PromoCell) in CORNING, CellBIND surface T75 flasks (Sigma). When the cells were 90% confluent, they were split and repassaged in new tissue culture flask at a ratio of 1:4.
Myogenic Differentiation
At passage 2 MSCs were re-seeded at a density of 1.5x10 5 cells onto T75 cell culture flasks.
When MSCs were 70% confluent, cells were cultured for 0, 3, 7, 14, 21 or 28 days in control medium: DMEM high glucose (Life Technologies), 10% FBS (Biochrom, Berlin, Germany), 1% penicillin-streptomycin solution (Life Technologies) and 1.2% fungicide (Biochrom) or smooth muscle differentiation medium (control media supplemented with 5ng/mL human recombinant PDGF-AB (Peprotech, Hamburg, Germany), 5 ng/mL recombinant human TGF-β1 (R&D Systems, Weisbaden-Nordenstadt, Germany) and 30 μM L-ascorbic acid (SigmaAldrich). Media were changed twice a week.
Osteogenic Differentiation
MSCs were seeded onto 6-well plates (Greiner Bio-One, Frickenhausen, Germany) at 5x10 4 cells/well for expansion in GMP expansion medium until they were 70% confluent. Differentiation was started by adding osteogenic induction media: low glucose DMEM high glucose (Life Technologies), 10% FBS (Biochrom), 0.1 μM dexamethasone (Fagron, Barsbüttel, Germany), 10 mM β-glycerophosphate (Sigma-Aldrich), 1% penicillin-streptomycin solution (Life Technologies) and 0.17 mM L-ascorbic acid (Sigma-Aldrich). Media were changed twice a week. At day 14, cells were fixed with ice-cold methanol and stained by von Kossa [27] .
Immunofluorescence
MSCs at passage 1 or primary human bladder SMCs (PromoCell) were seeded onto chamber slides (SARSTEDT, Nümbrecht, Germany) at a density of 6000 cells/chamber slide in 500 μL/ well GMP expansion medium. When cells were 90% confluent, medium was replaced with control or myogenic differentiation medium for MSCs, or SMC growth medium (PromoCell) for primary human bladder SMCs, respectively. After 14 days, cells were washed, fixed with ice-cold methanol and washed again. Samples were then incubated with the following antibodies diluted in PBS containing 0.1% BSA (Sigma-Aldrich): 1:100 rabbit anti-αSMA (Abcam, Cambridge, UK), 1:100 rabbit anti-transgelin (Santa Cruz Biotechnology, Heidelberg, Germany), 1:250 rabbit anti-calponin (Abcam) or 1:100 mouse anti-SM-MHC (Santa Cruz Biotechnology), followed by Cy™3-conjugated goat anti-rabbit or Cy™3-conjugated goat antimouse secondary antibody (dilution: 1:1000 for αSMA and transgelin; 1:500 for Calponin, 1:300 for SM-MHC; Dianova, Hamburg, Germany) for 30 min at RT. Cell nuclei were stained with DAPI, washed three times with PBS and mounted with mounting medium (Dako, Glostrup, Denmark). As a negative control cells were incubated with secondary antibody alone (data not shown). Digital microscopic images recorded in black and white and colorized to green with an exposure time of 1-1.5 s were taken with a CCD camera attached to an Axiovert M200 (Carl Zeiss, Jena, Germany) microscope at magnifications of 20x.
Flow Cytometry for αSMA
Expression of intracellular αSMA was explored by flow cytometry (FC) as described recently [29] . were prepared as stocks and frozen until use. Cells were held in voltage clamp mode by an EPC10 amplifier (HEKA, Lambrecht, Germany), and currents were filtered at 2.9 kHz using the internal Bessel filter, digitized and stored at 50 kHz. Cells were held at -70mV between the different recordings. Experiments were analyzed using the Processing and Analysis Tool developed by J. Bergsman and self-written macros in Igor Pro 6.35 (Wavemetrics, Lake Oswego, Oregon, USA).
Calcium Imaging
Global Ca 2+ transients were measured using fura-2 (fura- 
Contractility Assay
Potassium chloride (KCl)-induced contractile activity of the differentiated cells was measured using a modification of the method described in [31] . For generating fibrin hydrogels, the following working solutions were produced: fibrinogen (Sigma-Aldrich; 2mg/mL DMEM) and bovine thrombin (Sigma-Aldrich; 5U/mL PBS). Of these working solutions, 500μl fibrinogen per ml hydrogel and 20μl thrombin per ml hydrogel were mixed with 380μl low glucose DMEM and 100μl FBS for the generation of hydrogels (1.9 cm 2 ). Prior to polymerization, this suspension (500μl/well) was pipetted into 24-well tissue culture treated plates (Greiner bioone, Frickenhausen, Germany). After 30 min, during which the hydrogels polymerized at 37°C, 2500 MSCs or 1500 SMCs were added onto the hydrogel surface in 500μl culture medium. The cells were incubated on top of these hydrogel surfaces in their respective media at 37°C for 24h.
To initiate the contraction experiments, media was removed and 0.5 mL/well of physiological saline solution (PSS composed of 99.1% deionized water and 0.9% NaCl) and green Calcein AM-fluorescence dye (0.6:1000) were gently added until the hydrogels were completely submerged. The cells were incubated for 30 minutes in PSS to normalize prior to contraction. PSS was removed and 0.5 mL/well potassium physiological saline solution (KPSS composed of 99.1% deionized water and 0.9% KCl) was gently pipetted into the plate until the hydrogels were completely submerged. Digital images were recorded with a confocal laser scanning microscope (Zeiss LSM 510, Axio Vision 4.8) exactly 10 seconds and 3 minutes after the addition of KPSS. To ensure comparability across all recorded images, a similar magnification (10x) and a similar size of the recorded image field (1388 x 1040 pixel) were used throughout these experiments. The images of 70 MSCs in control media (from 3 donors on 24 hydrogels), 58 MSCs in differentiation media (from 3 donors on 24 hydrogels), and 62 SMCs (on 32 hydrogels) were selected for further analysis based on the criteria that they were i) in focus and ii) that the entire cell was within the image frame. The images of each individual cell at the time points of 10 seconds and 3 minutes were contrast-enhanced by 5% and side-by-side manually thresholded with ImageJ (NIH, http://imagej.nih.gov/ij) while comparing the resulting thresholds with the originally recorded images. Cellular length was measured using the commands "set measurements" and "analyze particles". Contraction was determined by the change in length observed between the time points 10 seconds and 3 minutes and was expressed as percentage of the initial length at 10 seconds.
Statistics
Statistical analyses were performed using SigmaPlot 11.0 using a nonparametric Kruskal-Wallis test followed by a post hoc Dunn-Holland-Wolfe test or a Wilcoxon Signed Rank Test. When only two groups were compared a paired t-test was performed. P values < 0.05 were considered significant.
Results

Expression of Contractile SMC Marker Genes Increases within 1-2 Weeks of Myogenic Differentiation
MSCs were first expanded in GMP expansion medium containing human plasma and pooled platelet lysate and then differentiated using a combination of TGF-β1, ascorbic acid and PDGF-AB. The gene expression of contractile myogenic markers was measured by qRT-PCR and analysed and expressed as fold increase with respect to control medium for that particular day of differentiation (Fig 1A) or as fold increase with respect to day 0 (Fig 1B) . When compared to control medium, differentiation of MSCs resulted in a significant increase in ACTA2 at days 3, 7, 14 and 28; TAGLN at days 3 and 28; MYH11 at days 3, 7 and 28; and CNN1 at days 3, 7, 14 and 28 ( Fig 1A) . In agreement with these results, when the expression of these markers were normalized with respect to day 0, the starting point of differentiation, there was a significant increase in ACTA2 at days 3, 7, 14 and 28; MYH11 at days 3 and 28; and CNN1 at days 3, 7, 14 and 28 expression compared to control media (Fig 1B) . In contrast, using this method of analysis TAGLN was not significantly increased compared to control media at any of the days investigated or compared to day 0 of differentiation. However, compared to day 0 of differentiation, ACTA2 and MYH11 were significantly increased at days 3 and 7, while CNN1 significantly increased at days 3, 14 and 21. This data demonstrates that myogenic differentiation already increases the expression of contractile marker genes ACTA2, MYH11 and CNN1 within 1-2 weeks of differentiation.
Myogenic Differentiation Results in Increased Expression of Contractile SMC Marker Proteins
We next compared the protein expression of these contractile SMC markers in primary human bladder SMCs compared to MSCs cultured in control or myogenic differentiation media for 14 days. Despite that some protein expression was already evident in MSCs in control media, differentiation of MSCs resulted in an increase in protein levels of alpha smooth muscle actin (αSMA), transgelin, calponin and smooth muscle myosin heavy chain (SM-MHC) protein levels at day 14 following myogenic differentiation as shown by immunofluorescent staining (Fig 2) . Moreover, the expression of these markers in differentiated MSCs were comparable to primary human bladder SMCs. To further confirm that the protein expression of myogenic markers was increased following differentiation using the TGF-β1, ascorbic acid and PDGF-AB cocktail, Western blots were performed on MSCs after expansion and after culturing MSCs in control media or differentiation media for 2 weeks. Western blotting using lysates of human bladder tissue (positive control; control 1) and PBMCs (negative control; control 2) compared to three different MSC donors confirmed a baseline expression of myogenic markers after expansion (day 0) and showed that in some cases culturing MSCs in control media (CM) increased expression of myogenic markers (Fig 3) , in agreement qRT-PCR data (Fig 1B) . Even though there was a baseline expression of these myogenic markers, we still observed an increase in expression of αSMA, transgelin, and calponin following myogenic differentiation (DM) compared to day 0 and compared to MSCs cultured in control media (CM). Variable results were observed with Expression levels of contractile SMC-specific genes. MSCs were expanded in GMP expansion medium until they were 70% confluent and at passage 2 treated with control medium (CM) or SMC differentiation medium (5 ng/mL human TGF-β1, 5 ng/mL human PDGF-AB and 30 μM ascorbic acid) for 0, 3, 7, 14, 21 and 28 days. Differentiation was analyzed by qRT-PCR. Transcript levels were calculated relative to GAPDH and PPIA. (A) Data was calculated relative to CM for that time point. * p<0.05 compared to CM at the respective day of differentiation. (B) Data was calculated relative to day 0, the starting point of differentiation. * p<0.05 compared to CM at the respective day of differentiation; † p<0.05 compared to day 0. n = 6-8. Error bars indicate SEM. expression of SM-MHC, in some cases an increase was observed and in other cases not (data not shown).
After MSCs Expansion αSMA Is Expressed in Some of the MSCs but Can Be further Elevated by Myogenic Differentiation
As the GMP-compliant expansion medium was enriched with PPL, we hypothesized that TGFβ1 and PDGF in the medium induced the base line expression of smooth muscle cell markers αSMA, transgelin or calponin observed in MSCs prior to differentiation (Fig 4) . To test this hypothesis we investigated the expression of the early myogenic marker αSMA [31] in MSCs before and after expansion of MSCs and after myogenic differentiation. To discriminate MSCs from other cells in the samples ex vivo, CD45 + hematopoietic cells were excluded and expression of αSMA was recorded in the CD271 + fraction of the mononuclear cells [32] . Flow cytometry results showed that expression of αSMA was not detected the CD45 -CD271 + MSCs ex vivo (Fig 4A) . In contrast, the CD45 -CD271 -mononuclear cells from bone marrow clearly contained αSMA (data not shown). However, after expansion of the cells, levels of intracellular αSMA increased in some of the MSCs (Fig 4B) suggesting that the expression of this marker was elevated by growth factors within the GMP expansion medium. This is not surprising since PLL is known to supply a wide variety of growth factors [33] , including TGFβ1 and PDGF employed for myogenesis in many studies [17, 22, 23, 26] and here (Figs 1-3 ). But not all MSCs expressed αSMA at elevated levels and some remained αSMA low as indicated by the broad histogram (Fig 4B) . After incubating the MSCs in differentiation medium the mean fluorescence intensity of αSMA expression shifted to a slightly higher signal intensity (Fig 4C) . This experiment confirmed our hypothesis that only a few MSCs express αSMA ex vivo, but after expansion under GMP-compliant conditions a considerable number of MSCs expresses αSMA. Moreover this showed that the expression of αSMA can be further elevated by myogenic differentiation media (Fig 4) , in agreement with the results shown in Figs 2 and 3.
Osteogenesis and Adipogenesis Does Not Occur in Myogenic Differentiation Medium
Since we have shown that bone marrow-derived MSCs have a higher osteogenic potential than placenta-derived MSCs [29, 34, 35] we wanted to determine if MSCs cultured in the myogenic medium containing TGF-β1, ascorbic acid and PDGF-AB tended to differentiate towards an osteogenic lineage. As expected, MSCs cultured in osteogenic differentiation medium resulted in strong von Kossa staining (Fig 5C) . In contrast, after 2 weeks of differentiation MSCs cultured in control medium or myogenic medium did not differentiate into osteoblasts as visualized by von Kossa staining (Fig 5A and 5B, respectively) . Similarly, primary human bladder SMCs stained with von Kossa chemistry did not show signs of osteogenesis when expanded in smooth muscle cell growth medium 2 ( Fig 5D) . It should be noted that in rare instances we Similarly we also investigated whether any adipogenesis occurred following myogenic differentiation. As expected, adipocytes were only observed in MSCs cultured in adipogenic differentiation medium (Fig 5G) . No lipid-containing vesicles were observed in MSCs cultured in control or myogenic medium (Fig 5E and 5F, respectively) . Similarly, primary human bladder SMCs stained with Oil Red O did not show signs of adipogenesis when expanded in smooth muscle cell growth medium 2 (Fig 5H) . These results show that myogenic differentiation does not lead to osteogenesis or adipogenesis.
Voltage-gated Na + Current Levels Were Sensitive to a Selective Sodium Channel Blocker that Blocks Neuromuscular Junctions
Since ion channels play an important role in regulating the contraction of urinary bladder smooth muscle [14] , electrophysiological experiments were performed on undifferentiated MSCs, differentiating MSCs and primary human bladder SMCs to assess the functional properties of the differentiating MSCs. When MSC from 2 patients were cultivated in FBS containing control medium (MSC-FBS), in both sources 40% of the cells investigated (4 out of 10) expressed a Na + current (Fig 6A top) , confirmed by the fact that this current could be blocked by the specific Na+ channel inhibitor tetrodotoxin (1 μM; TTX; a selective sodium channel blocker; Fig 6C) . The current density normalized to the cell surface was small with 0.43 ± 0.05 pA (Fig 6B, obtained at a holding potential of -20 mV). On the other hand, MSCs expanded in GMP expansion medium (MSC-GMP) only rarely expressed functional Na + channels. In fact only in cultures from 3 donors out of 18, MSC could be found, expressing Na + current densities of 1.4±0.2 pA/pF (n = 10). Hence voltage-activated Na + channels were rarely found in MSC-GMP. In contrast, after myogenic differentiation Na + currents were found in 40-60% of all cells investigated, depending on the time of differentiation. The current size in those cells peaked to 2.5±0.5 pA/pF at day 7 (n = 5; Fig 6A middle) following myogenic differentiation. Moreover, differentiated cells were similar to primary bladder SMCs (n = 20; Fig 6A bottom) . Hence the 
Smooth Muscle-Like Cells in Comparison to Bladder Smooth Muscle Cells
Na + current density of 3.1 ± 0.9 pA/pF in primary SMCs was not significantly different from those obtained at day 7 of differentiation. Interestingly, with progressing differentiation time the amplitude decreased again (Fig 6B) . Moreover, the Na + channels of both cell types, myogenically differentiated cells and bladder SMCs, were sensitive to the Na + specific blocker TTX 
Subtype
Ranolazine is a drug known to partially block Na v 1.4 and Na v 1.7 voltage-gated sodium channel subtypes [36] . Application at a concentration of 100 μM blocked voltage-activated Na + currents by approximately 30% for undifferentiated MSCs (n = 3), 40% for MSCs that were differentiated for 5-10 days (n = 5) or 13-21 days (n = 7) and 50% for SMCs (n = 4) (Fig 7A) . Pro- (Fig 7B) . In SMCs, pro-toxin II failed to inhibit the Na + current at a concentration of 2 nM, whereas 100 nM suppressed the current by 79% (n = 4; Fig 7C) (Fig 8A) , myogenically differentiated MSCs expressed a pronounced elevation in the cytosolic Ca 2+ in all cells investigated (n = 26 from 2 donors; Fig 8B) , whereas no increase in the intracellular Ca 2+ concentration was visible in undifferentiated MSCs (n = 45 from 3 donors; Fig 8C) . This was in line with the finding, that in neither MSC-GMP nor MSC-FBS Ca 2+ currents could be observed (data not shown), which is the key requirement for the sarcoplasmatic Ca 2+ release [13] . The elevation in bladder and differentiated MSCs was suppressed in the presence of 50 μM Cd
2+
, a potent inhibitor of voltage-gated Ca 2+ channels (n = 5 from 1 donor; Fig 8A and 8B, respectively) . This is an important finding since an increase in intracellular Ca 2+ concentration is a key process required for the activation of contraction in bladder smooth muscle [13] .
Differentiated MSCs and Bladder SMCs Express Big-Conductance Ca
2+
-activated K + Ion Channels and L-and T-Type Ca 2+ Ion Channels
To identify additional ion channels expressed in differentiated MSCs and bladder SMCs, we performed qRT-PCR for the gene expression of potassium and calcium ion channels that regulate contraction of bladder SMCs [38] [39] [40] . Like bladder SMCs, differentiated MSCs (day 7) showed a similar profile, with no significant differences between the two groups, in the expression of KCNMA1, CACNA1C and CACNA1H (Fig 9A and 9B, respectively) . Hence bladder SMCs and differentiated MSCs expressed high levels of KCNMA1 that encodes BK Ca channels, potassium channels characterized by their large conductance for potassium (K + ) ions through cell membranes and lower levels of CACNA1C and CACNA1H which encode for the Ca v 1.2 Ltype Ca 2+ channels and the Ca v 3.2 T-type Ca 2+ channels, respectively [39, 40] .
Differentiated MSCs and Bladder SMCs Contract in Response to K +
Contraction is commonly assessed by measuring changes in hydrogel dimensions. However our approach was to directly measure the contraction of the individual cells on top of the hydrogels, and not the effects of cellular contraction on hydrogel dimensions. To examine whether differentiated MSCs were able to contract, they were subjected to the effects of KCl (potassium physiological saline solution or KPSS). MSCs were cultured in control or differentiation medium for 7 days and compared to bladder SMCs. When comparing MSCs in control medium 10 seconds and 3 minutes after KPSS addition, no change in cellular length occurred (Fig 10A) . In contrast, when comparing MSCs in differentiation medium 10 seconds and 3 minutes after KPSS addition, a decrease in cellular length occurred (Fig 10D) . When comparing SMCs in their respective medium 10 seconds and 3 minutes after KPSS addition, a decrease in cellular length also occurred (Fig 10E) . Quantification of the changes in cellular length are depicted in Fig 10F. Both MSCs in differentiation medium and SMCs, but not MSCs in control medium, exhibited a significant decrease in cellular length when comparing their length at 10 seconds and 3 minutes after KPSS addition. Moreover, differentiated MSCs exhibited a significantly larger change in cellular length (-3.57 ± 0.52% of the initial cell length), compared to MSCs that were cultured in control medium (-0.31 ± 0.56%) and to SMCs (-1.86 ± 0.37%). These values depict the average contraction of the cells investigated. A small proportion of the differentiated MSCs and bladder SMCs did not contract. Hence 10 out of a total of 59 cells investigated for differentiated MSCs and 11 out of a total of 63 bladder cells investigated did not show a decrease in cell length suggesting that approximately 17% of both cell types did not exhibit the contractile phenotype. However it is noteworthy to state that a maximum contraction of 14.43% for differentiated cells and 12.91% for bladder SMCs was observed in some cells. Based on these results we conclude that KPSS treatment induced the contraction of differentiated MSCs, like bladder SMCs. Collectively, these results can be seen as an important step towards the successful differentiation of MSCs into smooth muscle-like cells with electrophysiological competence comparable to bladder SMCs. 
Discussion
The main finding of this study is that myogenically differentiating MSCs display marker gene expression and acquire electrophysiological competence comparable to bladder smooth muscle cells. While undifferentiated MSCs have been proposed to repair smooth muscle tissue of the urinary tract such as the bladder or urethral sphincter [9, 41] , this method depends on the surrounding cell-and tissue-based signals to induce the progenitor cells to differentiate into SMCs and some studies have shown that only a small portion of the undifferentiated MSCs differentiate into smooth muscle [10, 41] . MSCs could alternatively be pre-differentiated in vitro prior to implantation which may allow control over the signals required for SMC differentiation. In this study we measured the effects of GMP expansion on myogenic differentiation using a cocktail of TGF-β1, ascorbic acid and PDGF-AB and analyzed the expression of contractile myogenic markers in relation to the electrophysiological parameters to assess the functional role of the differentiated MSCs.
Specifically we show that within 1- [13, 31] . Hence, any changes in membrane potential can coordinate a contraction across large distances through gap junctions that allow ionic or electrical coupling of cells [13] . The expression of the myogenic markers observed in our study, in part, confirmed data from other groups who investigated differentiation of human bone marrow-derived MSCs into SMCs [17, 18, 22] . All of these phenotypic markers regulate or are directly involved in contraction of SMCs. For example αSMA, an early differentiation marker [13, 31, 42] , forms the thin filament of the classical contractile apparatus [43] . Transgelin, an early marker of smooth muscle differentiation [44] and calponin, an intermediate marker [13, 31, 42] , binds to actin to regulate SMC contraction [45] . Functionally, SM-MHC appears to be the most mature SMC marker [13, 31, 42] since it functions as an ATPase to generate force along actin filaments [46] . In contrast to a recent study [17] , in our study MYH11 was significantly increased on the gene expression level and in agreement with their results [17] SM-MHC was only slightly increased on the protein level. The differences that we observed may be due to the differences in tissue culture conditions such as the use of human products in the GMP expansion medium that we used (vs. FBS), the tissue culture conditions or the amount of TGF-β1 in the culture medium since we used double the concentration of TGF-β1 (5 ng/ml) [17] .
Because differentiation markers can also change in control medium (which contained FBS and hence growth factors) as shown in Fig 1B and Figs 2-4 , we also analyzed the data to account for this. However, even when comparing the fold change in gene expression relative to day 0, differentiated cells expressed significantly more ACTA2, CNN1 and the late myogenic differentiation marker MYH11. SMCs depend on all of these ion channels types for contraction [38, 39] . Like others [38] , we show that BKCa channel was highly expressed in bladder SMCs, but also in differentiated bone marrow-derived MSCs. In line with these results both cell types responded by contracting in response to K + . The BKCa has been proposed to be the most important physiologically relevant K + channel that regulates urinary bladder SMC function [38] . Like BKCa currents, T-and Ltype Ca 2+ currents have been found in SMCs from the human bladder [39, 40, 54] , but also in other urological tissues including the proximal urethra [55] and prostate [56] where they regulate smooth muscle contraction. TGF-β1 may be responsible for the expression of these ion channels in differentiating MSCs since it increased the expression of these ion channels, as well as contractile SMC myogenic genes, in adipose-derived MSCs [28] . We not only show that both differentiated MSCs and SMCs reacted with a transiently elevated cytosolic Ca 2+ response induced by K + depolarization, but also confirmed that differentiated MSCs and bladder SMCs were significantly more contractile in response to KCl than undifferentiated MSCs. Instead of measuring the effects of cellular contraction on hydrogel dimensions, contraction of individual cells was measured. In order to accurately measure individual cellular dimensional changes within hydrogel constructs one would need to record and reconstruct z-stacks. This would severely limit the amount of cells that could be measured simultaneously. To achieve a sufficiently high n number we measured contraction of individual cells on top of hydrogels, allowing a relatively high number of cells situated within the same focus plane to be assessed, which bypasses the need for z-stack recording. Thus our approach allowed us to record changes in cellular dimensions and hence contraction on a large number of individually recorded cells. Significant changes in cellular length were within the range of -3.57 ± 0.52% for differentiated MSCs and -1.86 ± 0.37% for bladder SMCs. These percentages are similar to what has previously been shown for bladder SMCs [57] , calculated as percentage in [58] . Based on all of these results we conclude that KCl treatment induced the contraction of differentiated MSCs, like bladder SMCs, and suggests that the contraction was due to the action of the contractile apparatus proteins and ion channels within the cells. Collectively this study indicates that within 7-14 days of myogenic induction a large proportion (up to 60-80%) of the differentiating cells achieve maturity, express SMC markers and exhibit functional electrophysiological parameters, including the ability to contract. Contractile and synthetic SMCs, which represent the two ends of a spectrum of SMCs with intermediate phenotypes often present, clearly show different morphologies. This phenomenon, referred to as phenotypic modulation, is well characterized for primary vascular SMCs [42, 59, 60] . Hence vascular SMCs in vitro and in vivo can alternate from a functional, contractile phenotype to a proliferative 'synthetic' phenotype and often present as a continuum of these phenotypes [31, 61] . Bladder SMCs have also been divided into phasic and tonic subtypes based on membrane properties and contractile behavior [13] . Hence, synthetic SMCs proliferate more than contractile SMCs, are dense, have a cobblestone morphology and contain many organelles essential to synthesize proteins [31, 42] . In contrast, contractile SMCs are elongated, exhibit the shape of a spindle, express all of the contractile phenotypic markers that make up a functional contractile apparatus and respond to signals and stimuli that endorse cell contraction. SMCs with a contractile phenotype also predominantly express BKCa channels [62] [63] [64] [65] and Ca V 1.2 (L-type voltage-gated Ca 2+ ) channels [66, 67] . Therefore the differentiated MSCs derived in this work seem to mainly consist of the contractile phenotype, as they are spindle-shaped, express genes and proteins involved in SMC contraction including myogenic markers and functional ion channels, and contract when exposed to the K + agonist.
This work constitutes a step forward in the pursuit of a better understanding of the expression of contractile myogenic markers in relation to the electrophysiological parameters over the course of in vitro differentiation of MSCs into smooth muscle-like cells and shows that electrophysiological characteristics of differentiated MSCs are comparable to bladder SMCs. This study could help in designing protocols aimed at urological regenerative medicine applications or where autologous smooth muscle cells are unavailable.
